Apathy: A major symptom in CADASIL

Objective:The frequency and impact of apathy in subcortical ischemic vascular dementia (SIVD) remain undetermined. The frequency, clinical, neuropsychological, and imaging correlates of apathy were assessed in a large cohort of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, a genetic model of SIVD. Methods:Apathy was diagnosed based on Neuropsychiatric Inventory assessment. Degree of disability was assessed by modified Rankin scale, cognitive impairment by Mattis Dementia Rating Scale (MDRS) and Mini-Mental State Examination (MMSE), autonomy by the Instrumental Activities of Daily Living (IADL) scale, and quality of life by SEP-59 self-questionnaire. Validated imaging methods were used to determine the total burden of cerebral lesions. Results:Among 132 patients, 54 (41%) were apathetic. Apathetic patients were older than nonapathetic subjects, had a lower MMSE and MDRS score, had more global disability, and were more limited in IADL. Apathetic patients were more frequently depressed compared to nonapathetic patients and more frequently presented additional neuropsychiatric symptoms. Multiple regression modeling showed a significant and independent association between apathy and a lower score of overall quality of life and between apathy and a higher load of white matter and lacunar lesions. Conclusions:The results suggest that apathy is common in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), appears in association with cognitive impairment, global functional disability, and severe neuropsychiatric symptoms during the course of the disease, and can occur separately from depression. Apathy has an independent impact on the overall quality of life in CADASIL. GLOSSARYCADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th edition; IADL = Instrumental Activities of Daily Living; ICC = intracranial cavity; LL = lacunar lesions; MDRS = Mattis Dementia Rating Scale; MMSE = Mini-Mental State Examination; mRS = modified Rankin scale; NA = not applicable because of insufficient observations; nCM = number of cerebral microhemorrhages; nLL = normalized volume of lacunar lesions; NPI = Neuropsychiatric Inventory; nWMH = normalized volume of white matter hyperintensities; QOL = quality of life; SIVD = subcortical ischemic vascular dementia; TIA = transient ischemic attack; WMH = white matter hyperintensities.

[1]  B. Vellas,et al.  L’Année gérontologique et Les cahiers de l’année gérontologique , 2009 .

[2]  A. Leentjens,et al.  The nosological position of apathy in clinical practice , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  J. Cummings,et al.  Positron emission tomography metabolic correlates of apathy in Alzheimer disease. , 2007, Archives of neurology.

[4]  Martin Dichgans,et al.  Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. , 2006, Brain : a journal of neurology.

[5]  B. Dubois,et al.  Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. , 2006, Cerebral cortex.

[6]  R. Porcher,et al.  Cognitive profile in CADASIL , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  P. Sachdev,et al.  Frequency and clinical, neuropsychological and neuroimaging correlates of apathy following stroke – the Sydney Stroke Study , 2005, Psychological Medicine.

[8]  W. Hauser,et al.  A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. , 2005, The Journal of neuropsychiatry and clinical neurosciences.

[9]  David Craig,et al.  A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[10]  M. O’Sullivan,et al.  Diffusion tensor imaging of thalamus correlates with cognition in CADASIL without dementia , 2004, Neurology.

[11]  J. Grace,et al.  Behavioral problems as predictors of functional abilities of vascular dementia patients. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[12]  I. Appollonio,et al.  Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease , 2002, Movement disorders : official journal of the Movement Disorder Society.

[13]  D. Neary,et al.  Behavior in Huntington's disease: dissociating cognition-based and mood-based changes. , 2002, The Journal of neuropsychiatry and clinical neurosciences.

[14]  Jane S. Paulsen,et al.  Neuropsychiatric aspects of Huntington's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[15]  I Litvan,et al.  Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[16]  J. Aharon-Peretz,et al.  Behavioral Differences between White Matter Lacunar Dementia and Alzheimer’s Disease: A Comparison on the Neuropsychiatric Inventory , 2000, Dementia and Geriatric Cognitive Disorders.

[17]  J. Coste,et al.  [Quality of life and multiple sclerosis: validation of the french version of the self-questionnaire (SEP-59)]. , 2000, Revue neurologique.

[18]  J. Cummings,et al.  Range of neuropsychiatric disturbances in patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[19]  A. Finset,et al.  Apathy and depressed mood in acquired brain damage: relationship to lesion localization and psychophysiological reactivity , 1999, Psychological Medicine.

[20]  M. Dichgans,et al.  The phenotypic spectrum of CADASIL: Clinical findings in 102 cases , 1998, Annals of neurology.

[21]  J. Weissenbach,et al.  Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients , 1997, The Lancet.

[22]  J. Cummings,et al.  The Neuropsychiatric Inventory , 1997, Neurology.

[23]  R. Marin,et al.  Apathy: Concept, Syndrome, Neural Mechanisms, and Treatment. , 1996, Seminars in clinical neuropsychiatry.

[24]  B. Dubois,et al.  Clinical spectrum of CADASIL: a study of 7 families , 1995, The Lancet.

[25]  S. Pappatà,et al.  Cytokines and acute-phase response in acute stroke. , 1995 .

[26]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[27]  F. Fazekas,et al.  The Mattis Dementia Rating Scale , 1994, Neurology.

[28]  R. Robinson,et al.  Apathy Following Cerebrovascular Lesions , 1993, Stroke.

[29]  C. Sherbourne,et al.  The RAND 36-Item Health Survey 1.0. , 1993, Health economics.

[30]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[31]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[32]  J. Matías‐Guiu,et al.  [Apathy in Parkinson's disease]. , 2010, Neurologia.

[33]  S. Pappatà,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a positron emission tomography study in two affected family members. , 1995, Stroke.

[34]  H. Mayberg,et al.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[35]  R. Marin,et al.  Apathy: a neuropsychiatric syndrome. , 1991, The Journal of neuropsychiatry and clinical neurosciences.